Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 7 January 2023 31 January 2024 31 January 2024 14576799 Dr A Aboalkaz Mrs S Aboalkaz iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14576799 2023-01-06 14576799 2024-01-31 14576799 2023-01-07 2024-01-31 14576799 frs-core:CurrentFinancialInstruments 2024-01-31 14576799 frs-bus:PrivateLimitedCompanyLtd 2023-01-07 2024-01-31 14576799 frs-bus:FilletedAccounts 2023-01-07 2024-01-31 14576799 frs-bus:Micro-entities 2023-01-07 2024-01-31 14576799 frs-bus:AuditExempt-NoAccountantsReport 2023-01-07 2024-01-31 14576799 frs-bus:Director1 2023-01-07 2024-01-31 14576799 frs-bus:Director2 2023-01-07 2024-01-31
Registered number: 14576799
A-Z Diagnostics Ltd
Unaudited Financial Statements
For the Period 7 January 2023 to 31 January 2024
Balance Sheet
Registered number: 14576799
31 January 2024
£
Fixed assets 2,638
Current assets 24,538
Creditors: Amounts Falling Due Within One Year (5,140 )
NET CURRENT ASSETS 19,398
TOTAL ASSETS LESS CURRENT LIABILITIES 22,036
Accruals and deferred income (749 )
NET ASSETS 21,287
CAPITAL AND RESERVES 21,287

Notes

1. General Information
A-Z Diagnostics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14576799 . The registered office is 8 Lakeside Drive, Cardiff, CF23 6DD.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr A Aboalkaz
Director
5 October 2024